Cellular Immune Response

JPT offers its expertise in discovery projects to define immunodominant epitopes from various antigens or proteomes as well as for the development of tailored immune monitoring tools such our unique  PepMix™ Peptide Pool and our PepTrack™ Peptide Library platforms:

  • Synthetic overlapping peptides that span entire antigen sequences
  • Provide excellent tools for the antigen specific stimulation of CD4+ and CD8+ T-cell responses in vitro
  • Used as independent readout systems to monitor clinical vaccination and immunotherapy trials
  • Applicable to reactivate polyclonal CD4+ and CD8+ T-cells specific for a spectrum of viral antigens for stem cell recipients in a FDA approved trial
  • High quality peptides designed for performance in cellular assays accompanying clinical trials

For discovery projects, JPT developed a unique and economical workflow for the proteome spanning T-cell epitope discovery using well established and commonly used T-cell assays such as ELISpot.

Partner with us

Contact: Tanja Kaan
T: +49-30-6392-7878
X: +49-30-6392-7888

Quality Assurance

All production is performed according to ISO 9001:2015 standards

Stay in touch and be the first to receive the latest news!